Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

The article suggests using safety measures and telemedicine for aesthetic dermatology during COVID-19, while some procedures can still be done safely.

A woman's hair loss after COVID-19 was likely due to a mix of pressure-induced alopecia and acute telogen effluvium.

Covid-19 can cause hair loss due to immune and psychological factors.

COVID-19 can cause hair loss, but specialists can help treat it.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

The COVID-19 quarantine in Turkey disrupted dermatological care, increased stress-related skin issues, and showed the need for psychological support and teledermatology.

COVID-19 may be linked to hair loss called Telogen Effluvium, affecting quality of life and self-esteem.

COVID-19 protective measures led to skin irritation, hair loss, and brittle nails; using skin-friendly products and a healthy diet is recommended.

COVID-19 recovery can lead to temporary hair loss called telogen effluvium.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Dermatologists helped identify COVID-19 through skin symptoms and managed skin issues during the pandemic, but more high-quality research is needed.

Zinc acetate hydrate may help reduce fatigue and hair loss in post-COVID-19 patients.

The COVID-19 pandemic changed the types of skin conditions seen at a clinic, with fewer patients and varying numbers of specific conditions.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

Some people who recover from COVID-19 continue to have symptoms like fatigue and cough for over 120 days, and some experience hair loss about 59 days after getting sick.

Insulin resistance linked to obesity may increase COVID-19 severity.

COVID-19 may cause hair loss due to infection stress or treatments.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

During the COVID-19 pandemic in Turkey, the most common skin problem for both kids and adults was acne.

Long COVID is more common in those with severe initial infections, but not linked to blood group.

ADAM17 could be a potential target for treating PCOS.

COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.

During the COVID-19 pandemic, some skin conditions became more common while others decreased.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

Many COVID-19 survivors experience long-term symptoms but still report satisfactory quality of life and return to work.